CCB Portal Please support MJHS Institute
Facebook Twitter YouTube LinkedIn

Interprofessional Webinar Series:
Consent to Care: The Why, When, and What

This webinar is presented in collaboration with the
National Hospice and Palliative Care Organization.

Funding Disclosure: No commercial funding has been accepted for the activity.

Date and Time: November 3, 2016, 12:30 PM – 1:30 PM ET (Live)

Location: Online at http://www.mjhspalliativeinstitute.org/e-learning/

Speaker Name and Title:
Pauline Lesage, MD, LLM
Physician Educator
MJHS Institute for Innovation in Palliative Care
New York, NY

Purpose: Illustrate the complexity of obtaining an informed consent, especially in the context of the patient lacking capacity.

Why Do I Need to Know This?

  1. It is an intrinsic topic to hospice and palliative care.
  2. It is the most common reason for ethics committee review.
  3. It is one of the most complex issues in medicine, ethics, and law.

Objectives:

    1. Discuss the context of informed consent
      1. Barriers to communication: physician, patient, family
      2. Decision-making models: paternalistic, informed choice, shared decision-making
    2. Define the elements of informed consent:
      1. Information
      2. Authorization
    3. Examine the decision-making process for patients lacking capacity:
      1. Legal principles
      2. Advance directives:
        1. Health Care Proxy
        2. Instructional directives
          1. Living will
          2. MOLST

Target Audience: palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, pharmacists, allied health professionals, fellows, residents, and medical students.

Criteria for Successful Completion:

    1. Attendance at entire session (mandatory for nurses and social workers)
    2. Submission of completed evaluation form (mandatory to receive CE/CME credit for MDs, nurses, social workers)
    3. Successful completion of a posttest; 80% passing grade (mandatory to receive CE credit for social workers)

Continuing Education Credits: 1.0

Continuing Education Accreditation:

Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Hospice and Palliative Care Organization (NHPCO) and MJHS. NHPCO is accredited by the ACCME to provide continuing medical education for physicians.

NHPCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: NHPCO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.

NHPCO designates this live activity for a maximum of 1.0 contact hour. Nurses should claim only the contact hours commensurate with the extent of their participation in the activity. Accredited status by ANCC refers only to continuing nursing education and does not imply endorsement of any commercial product discussed in conjunction with this activity.

Social Workers: NHPCO is an approved provider of continuing education contact hours by the National Association of Social Workers (Provider #886414158).

This educational activity has been approved for 1.0 Social Work continuing education contact hour. (Approval #886414158-5146)

MJHS Institute for Innovation in Palliative Care SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0242.

Fees:
Individual: $25 (includes CME/CE certificate)
Group: $65 + $5 per CME/CE certificate

Registration fees for webinars are not refundable.

System Requirements for Computers and Mobile Devices:
http://support.citrixonline.com/en_US/Webinar/help_files/G2W010003

Disclosures
Pauline Lesage, MD, LLM, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.

Russell K. Portenoy, MD, Planner, has indicated a relationship with Pfizer Inc. and with AstraZeneca Pharmaceuticals LP for research grant support.

No other Planning Committee Member has any disclosures.

Planning Committee Members
Barbara Bouton, MA, FT
Colleen Fleming-Damon, PhDc, APRN-BC, ACHPN-BC, C.T.
Steven R. Gardner, MPA, PAHM
Myra Glajchen, DSW
Jennifer Kennedy, RN, MA, BSN, CHC
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Judith A. Skretny

 

register-now-button